Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 184

1.

Guideline for the management of clinically localized prostate cancer: 2007 update.

Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen CM; AUA Prostate Cancer Clinical Guideline Update Panel.

J Urol. 2007 Jun;177(6):2106-31. No abstract available.

PMID:
17509297
[PubMed - indexed for MEDLINE]
2.

Medical management of advanced prostate cancer: a multidisciplinary team approach.

Bellmunt Molins J, Gelabert i Mas A.

Expert Rev Anticancer Ther. 2007 Jul;7(7):977-9. Review. No abstract available.

PMID:
17627457
[PubMed - indexed for MEDLINE]
3.

Assessing and treating patients with increasing prostate specific antigen following radical prostatectomy.

Sandler HM, Eisenberger MA.

J Urol. 2007 Sep;178(3 Pt 2):S20-4. Epub 2007 Jul 20. Review.

PMID:
17644123
[PubMed - indexed for MEDLINE]
4.

[Prostatectomy, brachytherapy, percutaneous irradiation. Which method helps your patients the most?].

Messer PM, Gottfried HW, Hautmann R, Röttinger EM.

MMW Fortschr Med. 2002 Jan 17;144(1-2):39-41. German.

PMID:
11847880
[PubMed - indexed for MEDLINE]
5.

Brachytherapy or radical prostatectomy: is there a preferred method for treating localized prostate cancer?

Stone NN.

BJU Int. 2004 Jan;93(1):5. No abstract available.

PMID:
14678357
[PubMed - indexed for MEDLINE]
6.

Prostate-specific antigen levels after radical prostatectomy versus brachytherapy.

Merrick GS, Butler WM, Grimm PD.

Urology. 1999 Apr;53(4):865-6. No abstract available.

PMID:
10197879
[PubMed - indexed for MEDLINE]
7.

Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.

Efstathiou JA, Skowronski RY, Coen JJ, Grocela JA, Hirsch AE, Zietman AL.

Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1302-8. doi: 10.1016/j.ijrobp.2007.11.073. Epub 2008 Feb 11.

PMID:
18262732
[PubMed - indexed for MEDLINE]
8.

[Practice guideline 'Prostate cancer: diagnosis and treatment'].

de Reijke TM, Battermann JJ, van Moorselaar RJ, de Jong IJ, Visser AP, Burgers JS.

Ned Tijdschr Geneeskd. 2008 Aug 9;152(32):1771-5. Review. Dutch.

PMID:
18754308
[PubMed - indexed for MEDLINE]
9.

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.

Tsai HK, D'Amico AV, Sadetsky N, Chen MH, Carroll PR.

J Natl Cancer Inst. 2007 Oct 17;99(20):1516-24. Epub 2007 Oct 9.

PMID:
17925537
[PubMed - indexed for MEDLINE]
Free Article
10.
11.

[Prostate cancer physiopathology, diagnosis and therapy].

Geay JF.

Soins. 2007 Mar;(713):34-7. French. No abstract available.

PMID:
17419567
[PubMed - indexed for MEDLINE]
12.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

Ann Intern Med. 2008 Mar 18;148(6):435-48. Epub 2008 Feb 4. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888.

PMID:
18252677
[PubMed - indexed for MEDLINE]
13.

PSA recurrence after brachytherapy for seed misplacement: a double-blind radiologic and pathologic work-up after salvage prostatectomy.

Gacci M, Serni S, Lapini A, Vittori G, Vignolini G, Nesi G, Carini M.

Prostate Cancer Prostatic Dis. 2008;11(1):99-101. Epub 2007 Oct 9.

PMID:
17923856
[PubMed - indexed for MEDLINE]
14.

[Update of treatment for prostate cancer].

Ito K.

Gan To Kagaku Ryoho. 2011 Jan;38(1):48-53. Japanese. No abstract available.

PMID:
21434292
[PubMed - indexed for MEDLINE]
15.

[Therapeutic options in localized prostate cancer].

Bastian PJ.

MMW Fortschr Med. 2010 May 13;152(19):43-4. German. No abstract available.

PMID:
20557002
[PubMed - indexed for MEDLINE]
16.

Current management of prostatic carcinoma.

Bahnson RR, Catalona WJ.

Prim Care. 1985 Dec;12(4):795-813. Review.

PMID:
3909178
[PubMed - indexed for MEDLINE]
17.

Relationship of biochemical outcome to percentage of positive biopsies in men with clinically localized prostate cancer treated with permanent interstitial brachytherapy.

Guzzo TJ, Levin BM, Lee R, Guo M, Chen Z, Whittington R, Tomaszewski J, Malkowicz SB.

Urology. 2008 Apr;71(4):723-7. doi: 10.1016/j.urology.2007.09.027.

PMID:
18387401
[PubMed - indexed for MEDLINE]
18.

Expectant management: an option for localized prostate cancer.

Khan MA, Partin AW.

Prostate Cancer Prostatic Dis. 2005;8(4):311-5. Review.

PMID:
16130016
[PubMed - indexed for MEDLINE]
19.

[Surgical and medical treatment for localized prostate cancer].

Kawai K.

Gan To Kagaku Ryoho. 2007 Jul;34(7):1002-5. Japanese.

PMID:
17637535
[PubMed - indexed for MEDLINE]
20.

Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001).

Villers A, Pommier P, Bataillard A, Fervers B, Bachaud JM, Berger N, Bertrand AF, Bouvier R, Brune D, Daver A, Fontaine E, Haillot O, Lagrange JL, Molinie V, Muratet JP, Pabot du Chatelard P, Peneau M, Prapotnich D, Ravery V, Richaud P, Rossi D, Soulie M; FNCLCC; AFU.

Br J Cancer. 2003 Aug;89 Suppl 1:S50-8. No abstract available.

PMID:
12915903
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk